Press release
UTI Drugs Market Is Expected to Generate Huge Acquisition |Major Vendors - Bayer AG, Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Cipla Inc.
UTI Drugs Market -Highlights
UTI drugs are used for the treatment of urinary tract infection caused by bacterial or fungal infections. World Health Organization (WHO) estimates that approximately 50 % of women have UTI at some point in their lives resulting in more than $1 million hospitalizations per year.
WHO estimates the cost of UTI infections to be annually greater than $1 billion? It has further been stated that chances of boys being diagnosed with UTI is 1% while chances of girls being diagnosed with UTI is 3 to 8%.
GET FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/2540
On the other hand market constraints includes excellent efficacy of present antibiotics specially quinolones, growing drug resistance, unmet clinical needs, increasing incidence of chronic diseases etc. However, the rise of drug resistance has created the need for novel acting antibiotic.
The future of UTI treatment seems to be development of biologics with greater market development especially with respect to poorly growing African market. The loss of patents, weakening developed pipelines and poor expenditure on health in African region had further constrained the market growth.
UTI Drugs Market -Key Players
Bayer AG
Novartis AG
Pfizer Inc.
F. Hoffmann-La Roche Ltd
AstraZeneca
Cipla Inc.
Dr. Reddy’s Laboratories Ltd.
UTI Drugs Market -Segmentation
The Middle East and Africa UTI drugs market has been segmented into drug class which includes quinolones, aminoglycosides, β-lactam, azoles and others. Among all these drug classes quinolones have the largest market value due to their broad variety and excellent efficacy. The share of aminoglycosides have been reduced by a small margin as this drug is resistance.
Thus the current trend in UTI treatment is combined drug regimen. The market threat includes a form of substandard, counterfeit and spurious drugs have emerged. However it has to be noted that a huge unmet need exists for these drugs in the Middle East and African region.
OBTAIN REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/mea-uti-drugs-market-2540
UTI Drugs Market -Regional Analysis
Depending on geographic region, UTI drugs market is segmented into following countries: UAE, Egypt, Saudi Arabia, Kuwait, Qatar and Oman; UAE is the largest market followed by Egypt. However the future market will be led by poorly developed parts of Africa due to large unmet needs.
Major Points form TOC for UTI Drugs Market Research Report – Forecast to 2023
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global UTI Drugs Market, By Type
Chapter 7. Global UTI Drugs Market, By Treatment
Chapter 8 Global UTI Drugs Market, By End User
Chapter 9. Global UTI Drugs Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release UTI Drugs Market Is Expected to Generate Huge Acquisition |Major Vendors - Bayer AG, Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Cipla Inc. here
News-ID: 1399333 • Views: …
More Releases from Market Research Future
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years.
Market Overview and Size
The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends.
Get Sample @ https://www.marketresearchfuture.com/sample_request/41217
Market Size and Growth
The global washable…
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
More Releases for UTI
Urinary Tract Infection (UTI) Treatment Market Expanding Solutions for Rising Gl …
Introduction
The urinary tract infection (UTI) treatment market is witnessing significant growth, driven by the increasing prevalence of UTIs globally, rising awareness of treatment options, and advances in medical technologies. UTIs affect millions of individuals each year, with women being disproportionately impacted. As antibiotic resistance becomes an increasing concern and healthcare providers explore alternative solutions, the market for UTI treatments continues to evolve.
This article explores the key factors driving the…
Uncomplicated Urinary Tract Infection (UTI) Treatment Market Growing Demand for …
Introduction
Urinary tract infections (UTIs) are among the most common bacterial infections affecting individuals worldwide, especially women. They occur when harmful bacteria enter the urinary tract, leading to inflammation and discomfort. While most UTIs are uncomplicated, meaning they are limited to the lower urinary tract (bladder and urethra), their frequency and impact on daily life highlight the importance of effective treatments. The UTI treatment market is experiencing significant growth, driven by…
Retail Logistics Market Worth Observing Growth | Panalpina, Exel, UTi Worldwide
The latest launched report on Global Retail Logistics Market delivers a transformation framework to understand how megatrends affect industry growth, taking into account the major disrupting forces creating uncertainties for every organisation in the Retail Logistics. Based on these outcomes, HTF MI outline plan for these volatile scenarios considering companies such as APL Logistics, Schneider National, Maersk Logistics, SembCorp Logistics (USA), Panalpina, Exel, UTi Worldwide, Kuehne + Nagel International, DHL…
Investigation for Investors in shares of Patterson-UTI Energy, Inc. (NASDAQ: PTE …
An investigation was announced concnering potential breaches of fiduciary duties by certain directors at Patterson-UTI Energy, Inc.
Investors who purchased shares of Patterson-UTI Energy, Inc. (NASDAQ: PTEN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Patterson-UTI Energy directors breached their fiduciary duties and caused damage to the company and its shareholders.
Houston, TX based Patterson-UTI…
UTI Treatment Market Therapeutic Assessment 2018-2023
Global and Chinese UTI Treatment Industry, 2018 Market Research Report:
The 'Global and Chinese UTI Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global UTI Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the UTI Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals…
Prevalence of Complicated Urinary Tract Infection (UTI) to Increase Globally
Over 60% physicians are likely to prescribe penicillin and combinations to treat urinary tract infections (UTIs), whereas a vast majority prescribe quinolones in their daily practice to treat complicated cases. A significant percentage of physicians also agreed that they prescribed nitrofurans to treat uncomplicated urinary tract infections in female patients. FMI’s survey also found that cephalosporin is the second-most common drug in the treatment of recurrent and complicated urinary tract…
